Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (ticker: HSAQ) is a cardiovascular medical device company that entered the public markets through a SPAC business combination with Health Sciences Acquisitions 2 Corp, which completed its IPO in 2021. The transaction brought Orchestra BioMed into the public arena as a post-combination registrant operating in the healthcare and life sciences sector, with a focus on developing biomedical technologies for the treatment of cardiovascular disease. The company filed an 8-K with the SEC on June 24, 2025, continuing its public reporting obligations as an active registrant. For full deal history, sponsor profiles, and real-time SEC filing alerts on Orchestra BioMed and hundreds of other SPAC transactions, sign up for SpacDesk.